Cytori Therapeutics Inc (CYTX) Jumps 8.95% on February 12

Equities Staff |

Cytori Therapeutics Inc (CYTX) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 8.95% to $0.14, representing a gain of $0.0119 per share. Some 895,891 shares traded hands on 1,081 trades, compared with an average daily volume of 1.5 million shares out of a total float of 158.49 million. The stock opened at $0.14 and traded with an intraday range of $0.15 to $0.14.

After today's gains, Cytori Therapeutics Inc reached a market cap of $22.96 million. Cytori Therapeutics Inc has had a trading range between $1.47 and $0.13 over the last year, and it had a 50-day SMA of $0.21 and a 200-day SMA of $0.41.

Cytori Therapeutics Inc is engaged in the development of novel treatments for cardiovascular disease and soft tissue injuries and burns.

Cytori Therapeutics Inc is based out of San Diego, CA and has some 78 employees. Its CEO is .

For a complete fundamental analysis analysis of Cytori Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for CYTX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

Airbnb

Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…